CJ. Inman
( out of 26 reviews )

CJ. Inman, MD, MS, BA, BS

Languages spoken: English

Clinical Locations

Primary Location

Eccles Primary Children's Outpatient Services

81 N Mario Capecchi Drive
Salt Lake City , UT 84113
801-213-3599
Get Directions

CJ Inman, MD, MS is an Assistant Professor in Pediatric Rheumatology at the University Of Utah School Of Medicine and Primary Children’s Medical Center. She received her medical degree from Drexel School of Medicine, completed her pediatric residency at the University of California at Irvine and her pediatric rheumatology fellowship at the Seattle Children’s Hospital/ University of Washington and earned her MS in Biomedical and Health Informatics from the University of Washington.

She is currently an Assistant Professor in Pediatric Rheumatology at the University Of Utah School Of Medicine and Primary Children’s Medical Center. As a pediatric rheumatologist she treats children with rheumatic diseases including juvenile idiopathic arthritis, systemic lupus erythematosus, juvenile dermatomyositis and vasculitis as well as autoinflammatory diseases such as periodic fever syndromes. Her research focuses on clinical research informatics evaluating data quality in clinical registries.

Specialties

Board Certification

American Board of Pediatrics (Pediatrics)
American Board of Pediatrics (Sub: Peds Rheumatology)

Patient Rating

4.9 /5
( out of 26 reviews )

The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers. The scale on which responses are measured is 1 to 5 with 5 being the best score.

2025-01-23
EXTERNAL SITE

Dr Inman is sincerely one of the best providers we have had the pleasure of working with. So intelligent and thorough!

2024-06-27
EXTERNAL SITE

Dr. C. Inman is by far the most compassionate, involved, responsive, forward thinking, researching medical professional that we have worked with. We are beyond grateful for her, her hard work, and dedication to those she serves. Dr. Inman researched for years for my daughter and would not give up until we found what condition she had, and how to treat it. She is a brilliant physician. More than that, she truly truly cares for my daughter. It's clear in her actions, responses and care. I'm not sure how we would have navigated the difficulties of the last 10 years without her driving the ship. Thank you thank you thank you for you, Dr. Inman!!

2024-06-26
EXTERNAL SITE

Dr Inman is great at listening and connecting. She remembers personal things about my daughter to show she knows her. She does research to learn better ways to treat her syndrome.

2023-02-02
EXTERNAL SITE

Dr. Inman is the only doctor I've ever had who truly listens to me when I express a concern or wanting to change a medication, she's great!

2023-02-02
EXTERNAL SITE

Dr. Inman is the only doctor I've ever had who truly listens to me when I express a concern or wanting to change a medication, she's great!

Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

CJ Inman, MD, MS is an Assistant Professor in Pediatric Rheumatology at the University Of Utah School Of Medicine and Primary Children’s Medical Center. She received her medical degree from Drexel School of Medicine, completed her pediatric residency at the University of California at Irvine and her pediatric rheumatology fellowship at the Seattle Children’s Hospital/ University of Washington and earned her MS in Biomedical and Health Informatics from the University of Washington.

She is currently an Assistant Professor in Pediatric Rheumatology at the University Of Utah School Of Medicine and Primary Children’s Medical Center. As a pediatric rheumatologist she treats children with rheumatic diseases including juvenile idiopathic arthritis, systemic lupus erythematosus, juvenile dermatomyositis and vasculitis as well as autoinflammatory diseases such as periodic fever syndromes. Her research focuses on clinical research informatics evaluating data quality in clinical registries.

Board Certification and Academic Information

Academic Departments Pediatrics -Assistant Professor (Clinical)
Board Certification
American Board of Pediatrics (Pediatrics)
American Board of Pediatrics (Sub: Peds Rheumatology)

Education history

Undergraduate San Diego State University
Undergraduate Orange Coast Community College
Undergraduate Women's Studies - UCLA B.A.
Undergraduate Neuroscience - UCLA B.S.
Professional Medical Medicine - Drexel University College of Medicine M.D.
Residency Pediatrics - University of California - Irvine Medical Center Resident
Fellowship Pediatric Rheumatology - University of Washington Fellow
Graduate Training Biomedical Health Informatics - University of Washington Master's

Selected Publications

Journal Article

  1. Ruperto N, Brunner HI, Pacheco-Tena C, Louw I, Vega-Cornejo G, Spindler AJ, Kingsbury DJ, Schmeling H, Borzutzky A, Cuttica R, Inman CJ, Malievskiy V, Scott C, Keltsev V, Terreri MT, Viola DO, Xavier RM, Fernandes TAP, Velázquez MDRM, Henrickson M, Clark MB, Bensley KA, Li X, Lo KH, Leu JH, Hsu CH, Hsia EC, Xu Z, Martini A, Lovell DJ, Pediatric Rheumatology Collaborative Study Group (PRCSG) and the Paediatric Rheumatology International Trials Organisation (PRINTO) (2021). Open-label phase 3 study of intravenous golimumab in patients with polyarticular juvenile idiopathic arthritis. Rheumatology (Oxford, England), 60(10), 4495-4507.
  2. Barfuss SB, Truong DT, James KE, Inman CJ, Husain SA, Williams RV, Minich LL, Mart C (2022). Left ventricular thrombus in the multisystem inflammatory syndrome in children associated with COVID-19. Annals of pediatric cardiology, 15(1), 90-93.
  3. Case S, Hill CL, Shrader P, Dennos A, Phillips T, Schanberg LE, von Scheven E, Barbour K, Knight AM, Hersh A, Son M, CARRA Registry Investigator (2025). Disease activity trajectories in paediatric lupus and associations with socioeconomic factors and patient-reported pain. Lupus science & medicine, 12(2),
  4. Soulsby WD, Olveda R, He J, Berbert L, Weller E, Barbour KE, Greenlund KJ, Schanberg LE, von Scheven E, Hersh A, Son MBF, Chang J, Knight A, CARRA Registry Investigator (2025). Racial Disparities and Achievement of the Low Lupus Disease Activity State: A CARRA Registry Study. Arthritis care & research, 77(1), 38-49.
  5. Smitherman EA, Chahine RA, Beukelman T, Lewandowski LB, Rahman AKMF, Wenderfer SE, Curtis JR, Hersh AO, CARRA Registry Investigator (2023). Childhood-Onset Lupus Nephritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: Short-Term Kidney Status and Variation in Care. Arthritis care & research, 75(7), 1553-1562.
  6. Srinivasalu H, Treemarcki EB, Rumsey DG, Weiss PF, Colbert RA, CARRA Spondyloarthritis Workgroup and the CARRA Registry Investigator (2023). Modified Juvenile Spondyloarthritis Disease Activity Index in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. The Journal of rheumatology, 50(4), 532-537.
  7. Hersh AO, Case SM, Son MB, CARRA Registry Investigator (2018). Predictors of disability in a childhood-onset systemic lupus erythematosus cohort: results from the CARRA Legacy Registry. Lupus, 27(3), 494-500.
  8. Maller J, Fox E, Park KT, Paul SS, Baszis K, Borocco C, Prahalad S, Quartier P, Reinhardt A, Schonenberg-Meinema D, Shipman-Duensing L, Terreri MT, Simard J, Lavi I, Chalom E, Hsu J, Zisman D, Mellins ED, CARRA Legacy Registry Investigator (2021). Inflammatory Bowel Disease in Children With Systemic Juvenile Idiopathic Arthritis. The Journal of rheumatology, 48(4), 567-574.
  9. Dave I, Estroff B, Gergely T, Rostad CA, Ponder LA, McCracken C, Prahalad S, CARRA Registry Investigator (2021). Impact of the Season of Birth on the Development of Juvenile Idiopathic Arthritis in the United States: A Nationwide Registry-based Study. The Journal of rheumatology, 48(12), 1856-1862.
  10. Orandi AB, Dharnidharka VR, Al-Hammadi N, Baszis KW, CARRA Legacy Registry Investigator (2018). Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis. Pediatric rheumatology online journal, 16(1), 84.
  11. Prahalad S, McCracken CE, Ponder LA, Angeles-Han ST, Rouster Stevens KA, Vogler LB, Langefeld CD, Thompson SD, Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry Investigator (2016). Familial autoimmunity in the Childhood Arthritis and Rheumatology Research Alliance registry. Pediatric rheumatology online journal, 14(1), 14.
  12. Fitzpatrick L, Broadaway KA, Ponder L, Angeles-Han ST, Jenkins K, Rouster-Stevens K, Pelajo CF, Conneely K, Epstein MP, Lopez-Benitez J, Vogler LB, Prahalad S, CARRA Registry Investigator (2016). Phenotypic Characterization of Juvenile Idiopathic Arthritis in African American Children. The Journal of rheumatology, 43(4), 799-803.
  13. Neely J, Long CS, Sturrock H, Kim S, Childhood Arthritis and Rheumatology Research Alliance Registry Investigator (2019). Association of Short-Term Ultraviolet Radiation Exposure and Disease Severity in Juvenile Dermatomyositis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. Arthritis care & research, 71(12), 1600-1605.
  14. Henderson LA, Zurakowski D, Angeles-Han ST, Lasky A, Rabinovich CE, Lo MS, Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry Investigator (2016). Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry. Pediatric rheumatology online journal, 14(1), 9.
  15. Connelly M, Weiss JE, for the CARRA Registry Investigator (2019). Pain, functional disability, and their Association in Juvenile Fibromyalgia Compared to other pediatric rheumatic diseases. Pediatric rheumatology online journal, 17(1), 72.
  16. Rubinstein TB, Mowrey WB, Ilowite NT, Wahezi DM, Childhood Arthritis and Rheumatology Research Alliance INVESTIGATOR (2018). Delays to Care in Pediatric Lupus Patients: Data From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. Arthritis care & research, 70(3), 420-427.
  17. Boneparth A, Ilowite NT, CARRA Registry Investigator (2014). Comparison of renal response parameters for juvenile membranous plus proliferative lupus nephritis versus isolated proliferative lupus nephritis: a cross-sectional analysis of the CARRA Registry. Lupus, 23(9), 898-904.
  18. Stevens BE, Torok KS, Li SC, Hershey N, Curran M, Higgins GC, Moore KF, Egla Rabinovich C, Dodson S, Stevens AM, Childhood Arthritis and Rheumatology Research Alliance Registry Investigator (2018). Clinical Characteristics and Factors Associated With Disability and Impaired Quality of Life in Children With Juvenile Systemic Sclerosis: Results From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. Arthritis care & research, 70(12), 1806-1813.
  19. Tory H, Zurakowski D, Kim S, CARRA Juvenile Dermatomyositis Quality Measures Workgroup for the CARRA Registry Investigator (2020). Patient and physician discordance of global disease assessment in juvenile dermatomyositis: findings from the Childhood Arthritis & Rheumatology Research Alliance Legacy Registry. Pediatric rheumatology online journal, 18(1), 5.
  20. Angeles-Han ST, Pelajo CF, Vogler LB, Rouster-Stevens K, Kennedy C, Ponder L, McCracken C, Lopez-Benitez J, Drews-Botsch C, Prahalad S, CARRA Registry Investigator (2013). Risk markers of juvenile idiopathic arthritis-associated uveitis in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. The Journal of rheumatology, 40(12), 2088-96.
  21. Wu EY, Li SC, Torok KS, Virkud YV, Fuhlbrigge RC, Rabinovich CE, Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry Investigator (2019). Baseline Description of the Juvenile Localized Scleroderma Subgroup From the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. ACR open rheumatology, 1(2), 119-124.
  22. Weiss JE, Schikler KN, Boneparth AD, Connelly M, CARRA Registry Investigator (2019). Demographic, clinical, and treatment characteristics of the juvenile primary fibromyalgia syndrome cohort enrolled in the Childhood Arthritis and Rheumatology Research Alliance Legacy Registry. Pediatric rheumatology online journal, 17(1), 51.
  23. Kimura Y, Grevich S, Beukelman T, Morgan E, Nigrovic PA, Mieszkalski K, Graham TB, Ibarra M, Ilowite N, Klein-Gitelman M, Onel K, Prahalad S, Punaro M, Ringold S, Toib D, Van Mater H, Weiss JE, Weiss PF, Schanberg LE, CARRA Registry Investigator (2017). Pilot study comparing the Childhood Arthritis & Rheumatology Research Alliance (CARRA) systemic Juvenile Idiopathic Arthritis Consensus Treatment Plans. Pediatric rheumatology online journal, 15(1), 23.
  24. Chang MH, Barbar-Smiley F, Akoghlanian S, Drew J, Angeles-Han ST, Quinlan-Waters M, Bohnsack JF, Cooper AM, Edelheit B, Twachtman-Bassett J, Lerman MA, Nanda K, Rabinovich CE, Lo MS, CARRA Uveitis Workgroup and the CARRA Registry Investigator (2024). Implementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research. Pediatric rheumatology online journal, 22(1), 88.
  25. Saper VE, Tian L, Verstegen RHJ, Conrad CK, Cidon M, Hopper RK, Kuo CS, Osoegawa K, Baszis K, Bingham CA, Ferguson I, Hahn T, Horne A, Isupova EA, Jones JT, Kasapcopur Ö, Klein-Gitelman MS, Kostik MM, Ozen S, Phadke O, Prahalad S, Randell RL, Sener S, Stingl C, Abdul-Aziz R, Akoghlanian S, Al Julandani D, Alvarez MB, Bader-Meunier B, Balay-Dustrude EE, Balboni I, Baxter SK, Berard RA, Bhattad S, Bolaria R, Boneparth A, Cassidy EA, Co DO, Collins KP, Dancey P, Dickinson AM, Edelheit BS, Espada G, Flanagan ER, Imundo LF, Jindal AK, Kim HA, Klaus G, Lake C, Lapin WB, Lawson EF, Marmor I, Mombourquette J, Ogunjimi B, Olveda R, Ombrello MJ, Onel K, Poholek C, Ramanan AV, Ravelli A, Reinhardt A, Robinson AD, Rouster-Stevens K, Saad N, Schneider R, Selmanovic V, Sefic Pasic I, Shenoi S, Shilo NR, Soep JB, Sura A, Taber SF, Tesher M, Tibaldi J, Torok KS, Tsin CM, Vasquez-Canizares N, Villacis Nunez DS, Way EE, Whitehead B, Zemel LS, Sharma S, Fernández-Viña MA, Mellins ED, CARRA Registry Investigator (2024). Interleukin (IL)-1/IL-6-Inhibitor-Associated Drug Reaction With Eosinophilia and Systemic Symptoms (DReSS) in Systemic Inflammatory Illnesses. The journal of allergy and clinical immunology. In practice, 12(11), 2996-3013.e7.
  26. Neely J, Sabbagh SE, Dvergsten J, Madubata C, Berthier CC, Zheng Z, Goudsmit C, Matossian S, Ferris SP, Fragiadakis GK, Sirota M, Kahlenberg JM, Kim H, Turnier JL, CARRA Registry Investigators and CARRA Translational Medicine for Juvenile Myositis Working Grou (2025). Discovery of tissue-specific proteomic signatures in juvenile dermatomyositis highlights pathways reflecting persistent disease activity, clinical heterogeneity, and myositis-specific autoantibody subtype. Annals of the rheumatic diseases, 84(11), 1836-1851.
  27. Correll C, Burciu A, Bansal A, Dennos A, Narayanswamy D, Aubrun E, Schanberg LE, Yuhan L, Schneider R, Balevic S, Kimura Y, Beukelman T, CARRA Registry investigator (2025). Long-term safety of canakinumab in patients with systemic juvenile idiopathic arthritis: 5-year results from the Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry. Pediatric rheumatology online journal, 23(1), 105.
  28. Srinivasalu H, Beukelman T, Dennos A, Chen A, Correll C, Ringold S, Stephen Balevic for the CARRA Registry Investigator (2025). Juvenile Psoriatic Arthritis Inception Cohort in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: Characteristics and Early Disease Outcomes. The Journal of rheumatology, 52(10), 1013-1020.
  29. Mannion ML, Aswani MS, Hearld KR, Smitherman EA, Timmerman L, Curtis JR, CARRA Registry Investigator (2025). Disease activity at two consecutive registry visits and subsequent medication escalation for patients with juvenile idiopathic arthritis in the CARRA registry. Pediatric rheumatology online journal, 23(1), 77.
  30. Samad A, Stoll ML, Lavi I, Hsu JJ, Strand V, Robinson TN, Mellins ED, Zisman D, CARRA Legacy Registry Investigator (2018). Adiposity in Juvenile Psoriatic Arthritis. The Journal of rheumatology, 45(3), 411-418.
  31. Liu K, Tomlinson G, Reed AM, Huber AM, Saarela O, Bout-Tabaku SM, Curran M, Dvergsten JA, Eberhard BA, Jung LK, Kim S, Ringold S, Rouster-Steven KA, Tesher M, Wahezi DM, Feldman BM, CARRA Registry Investigator (2021). Pilot Study of the Juvenile Dermatomyositis Consensus Treatment Plans: A CARRA Registry Study. The Journal of rheumatology, 48(1), 114-122.
  32. Weiss PF, Brandon TG, Aggarwal A, Burgos-Vargas R, Colbert RA, Horneff G, Laxer RM, Minden K, Ravelli A, Ruperto N, Smith JA, Stoll ML, Tse SM, Van den Bosch F, Maksymowych WP, Lambert RG, Biko DM, Chauvin NA, Francavilla ML, Jaremko JL, Herregods N, Kasapcopur O, Yildiz M, Srinivasalu H, Lovell DJ, Nigrovic PA, Foeldvari I, Klein-Gitelman MS, Ozen S, Naden R, Hendry AM, Joos (2024). Classification Criteria for Axial Disease in Youth With Juvenile Spondyloarthritis. Arthritis & rheumatology (Hoboken, N.J.), 76(12), 1797-1808.
  33. Zisman D, Gladman DD, Stoll ML, Strand V, Lavi I, Hsu JJ, Mellins ED, CARRA Legacy Registry Investigator (2017). The Juvenile Psoriatic Arthritis Cohort in the CARRA Registry: Clinical Characteristics, Classification, and Outcomes. The Journal of rheumatology, 44(3), 342-351.
  34. Correll CK, Stryker S, Collier D, Phillips TA, Dennos AC, Balevic SJ, Beukelman T, CARRA Registry Investigator (2023). Occurrence of adverse events and change in disease activity after initiation of etanercept in paediatric patients with juvenile psoriatic arthritis in the CARRA Registry. RMD open, 9(2),
  35. Ringold S, Ong MS, Tomlinson G, Natter MD, Schanberg LE, Del Gaizo V, Feldman BM, Murphy KL, Kimura Y, CARRA Registry STOP'JIA Investigator (2025). Three-Year Outcomes and Latent Class Trajectory Analysis of the Childhood Arthritis and Rheumatology Research Alliance Polyarticular JIA Consensus Treatment Plans Study. Arthritis & rheumatology (Hoboken, N.J.), 77(10), 1433-1441.
  36. Beukelman T, Kimura Y, Ilowite NT, Mieszkalski K, Natter MD, Burrell G, Best B, Jones J, Schanberg LE, CARRA Registry Investigator (2017). The new Childhood Arthritis and Rheumatology Research Alliance (CARRA) registry: design, rationale, and characteristics of patients enrolled in the first 12 months. Pediatric rheumatology online journal, 15(1), 30.
  37. Roberts JE, Williams K, Dallas J, Eckert M, Huie L, Smitherman E, Soulsby WD, Zhao Y, Son MBF, CARRA Registry Investigator (2023). Insurance Status and Tumor Necrosis Factor Inhibitor Initiation Among Children With Juvenile Idiopathic Arthritis in the CARRA Registry. The Journal of rheumatology, 50(8), 1047-1057.
  38. Randell RL, Reeve BB, Weitzman ER, von Scheven E, Zigler CK, Li Z, Mann CM, Hernandez A, Lin L, Reyes C, Schanberg LE, with the CARRA Registry Investigator (2024). Pain Interference in Juvenile Idiopathic Arthritis. The Journal of rheumatology, 51(11), 1119-1124.
  39. Eloseily E, Riordan ME, Mahmoud I, Clark A, Chang ML, Russell A, Natter M, Thornton S, Canna S, Co DO, DeGuzman M, Kimura Y, Schulert GS, CARRA Registry Investigators, CARRA FROST Investigators, CARRA Registry SJIA'LD Cohort Investigator (2025). Baseline Clinical Features and Biomarker Profiles of the Childhood Arthritis and Rheumatology Research Alliance Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease Cohort. Arthritis care & research,
  40. AlAhmed O, Sivaraman V, Moore-Clingenpeel M, Ardoin SP, Bout-Tabaku S, CARRA registry investigator (2020). Autoimmune thyroid diseases, autoimmune hepatitis, celiac disease and type 1 diabetes mellitus in pediatric systemic lupus erythematosus: Results from the CARRA Legacy Registry. Lupus, 29(14), 1926-1936.
  41. Borgia RE, Gurka MJ, Filipp SL, Elder M, Cardel M, Shiff NJ, CARRA Registry Investigator (2023). Race, ethnicity and patient-reported outcomes in childhood-onset systemic lupus erythematosus. Clinical and experimental rheumatology, 41(1), 186-194.
  42. Riskalla MM, Barbar-Smiley FA, Marka NA, Lerman MA, CARRA Registry investigator (2025). Uveitis treatment in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry: response to tumour necrosis factor inhibitors. Clinical and experimental rheumatology, 43(5), 946-952.
  43. Challa D, Crowson CS, Niewold TB, Reed AM, CARRA Legacy Registry Investigator (2018). Predictors of changes in disease activity among children with juvenile dermatomyositis enrolled in the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry. Clinical rheumatology, 37(4), 1011-1015.
  44. Brunner HI, Schanberg LE, Kimura Y, Dennos A, Co DO, Colbert RA, Fuhlbrigge RC, Goldmuntz E, Kingsbury DJ, Patty-Resk C, Mintz S, Onel K, Rider LG, Schneider R, Watts A, von Scheven E, Lovell DJ, Beukelman T, PRCSG Advisory Council and the CARRA Registry Investigator (2020). New Medications Are Needed for Children With Juvenile Idiopathic Arthritis. Arthritis & rheumatology (Hoboken, N.J.), 72(11), 1945-1951.
  45. Randell RL, Schanberg LE, Beard C, Phillips T, Hornik CP, Cohen-Wolkowiez M, Balevic SJ, with the CARRA Registry investigator (2025). Effect of an Electronic Pill Bottle on Hydroxychloroquine Adherence in Pediatric Lupus: Results of a Novel Direct-to-Family Pilot Trial. ACR open rheumatology, 7(1), e11780.
  46. Balevic SJ, Randell R, Weiner D, Beard C, Schanberg LE, Hornik CP, Cohen-Wolkowiez M, Gonzalez D, with the CARRA Registry investigator (2022). Pharmacokinetics of hydroxychloroquine in paediatric lupus: data from a novel, direct-to-family clinical trial. Lupus science & medicine, 9(1),
  47. Beukelman T, Ringold S, Davis TE, DeWitt EM, Pelajo CF, Weiss PF, Kimura Y, CARRA Registry Investigator (2012). Disease-modifying antirheumatic drug use in the treatment of juvenile idiopathic arthritis: a cross-sectional analysis of the CARRA Registry. The Journal of rheumatology, 39(9), 1867-74.
  48. Ringold S, Beukelman T, Nigrovic PA, Kimura Y, CARRA Registry Site Principal Investigator (2013). Race, ethnicity, and disease outcomes in juvenile idiopathic arthritis: a cross-sectional analysis of the Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry. The Journal of rheumatology, 40(6), 936-42.
  49. Smitherman EA, Chahine RA, Bitencourt N, Rahman AKMF, Lawson EF, Chang JC, CARRA Registry Investigators and CARRA Transition Workgrou (2023). Patient-Reported Outcomes Among Transition-Age Young Adults With Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry. The Journal of rheumatology, 50(1), 98-106.
  50. Hausmann JS, Vizcaino-Riveros J, Marin AC, Minegishi M, Cox R, Chang ML, Schanberg LE, Natter M, Weitzman ER, CARRA Legacy Registry Investigator (2022). Feasibility and Efficacy of Online Strategies to Recruit Parents of Children With Rheumatic Diseases for Research. ACR open rheumatology, 4(5), 410-416.
  51. Phillippi K, Hoeltzel M, Byun Robinson A, Kim S, Childhood Arthritis and Rheumatology Research Alliance (CARRA) Legacy Registry Investigator (2017). Race, Income, and Disease Outcomes in Juvenile Dermatomyositis. The Journal of pediatrics, 184, 38-44.e1.
  52. Driest KD, Sturm MS, O'Brien SH, Spencer CH, Stanek JR, Ardoin SP, CARRA Registry Investigator (2016). Factors associated with thrombosis in pediatric patients with systemic lupus erythematosus. Lupus, 25(7), 749-53.
  53. Li SC, Rabinovich CE, Becker ML, Torok KS, Ferguson PJ, Dedeoglu F, Hong S, Sivaraman V, Laxer RM, Stewart K, Ibarra MF, Mason T 2nd, Higgins G, Pope E, Li X, Lozy T, Fuhlbrigge RC, CARRA Registry Investigator (2024). Capturing the Range of Disease Involvement in Localized Scleroderma: The Localized Scleroderma Total Severity Scale. Arthritis care & research, 76(5), 616-626.
  54. Balmuri N, Soulsby WD, Cooley V, Gerber L, Lawson E, Goodman S, Onel K, Mehta B, CARRA Registry Investigators (2021). Community poverty level influences time to first pediatric rheumatology appointment in Polyarticular Juvenile Idiopathic Arthritis. Pediatric rheumatology online journal, 19(1), 122.
  55. Costello A, Twilt M, Lerman MA, CARRA Registry Investigator (2024). Provider assessment of the temporomandibular joint in Juvenile idiopathic arthritis: a retrospective analysis from the CARRA database. Pediatric rheumatology online journal, 22(1), 41.
  56. Neely J, Ardalan K, Huber A, Kim S, Childhood Arthritis and Rheumatology Research Alliance Investigator (2022). Baseline characteristics of children with juvenile dermatomyositis enrolled in the first year of the new Childhood Arthritis and Rheumatology Research Alliance registry. Pediatric rheumatology online journal, 20(1), 50.
  57. Hetrick RL, Harter M, Woo JMP, Rodriguez M, Rakestraw A, Tarvin SE, CARRA Health Equity Research Workgroup and the CARRA Registry investigator (2026). Demographic and disease representativeness of Childhood Arthritis and Rheumatology Research Alliance (CARRA) Registry participants with lupus: a single center retrospective cohort. Pediatric rheumatology online journal, 24(1),
  58. Beukelman T, Tomlinson G, Nigrovic PA, Dennos A, Del Gaizo V, Jelinek M, Riordan ME, Schanberg LE, Mohan S, Pfeifer E, Kimura Y, CARRA FROST Investigator (2022). First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans. Pediatric rheumatology online journal, 20(1), 113.
  59. Ringold S, Dennos AC, Kimura Y, Beukelman T, Shrader P, Phillips TA, Kohlheim M, Schanberg LE, Yeung RSM, Horton DB, Childhood Arthritis and Rheumatology Research Alliance Registry Investigator (2023). Disease Recapture Rates After Medication Discontinuation and Flare in Juvenile Idiopathic Arthritis: An Observational Study Within the Childhood Arthritis and Rheumatology Research Alliance Registry. Arthritis care & research, 75(4), 715-723.
  60. Shiff NJ, Shrader P, Correll CK, Dennos A, Phillips T, Beukelman T, CARRA Registry Investigator (2023). Trajectories of disease activity in patients with JIA in the Childhood Arthritis and Rheumatology Research Alliance Registry. Rheumatology (Oxford, England), 62(2), 804-814.
  61. Kimura Y, Schanberg LE, Tomlinson GA, Riordan ME, Dennos AC, Del Gaizo V, Murphy KL, Weiss PF, Natter MD, Feldman BM, Ringold S, CARRA STOP-JIA Investigator (2021). Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans. Arthritis & rheumatology (Hoboken, N.J.), 73(10), 1898-1909.
  62. Mannion ML, Xie F, Beukelman T, CARRA Registry Investigator (2022). Investigation of Inactive Disease States Among Patients With Juvenile Idiopathic Arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry. ACR open rheumatology, 4(9), 825-831.
  63. Soulsby WD, Balmuri N, Cooley V, Gerber LM, Lawson E, Goodman S, Onel K, Mehta B, CARRA Registry Investigator (2022). Social determinants of health influence disease activity and functional disability in Polyarticular Juvenile Idiopathic Arthritis. Pediatric rheumatology online journal, 20(1), 18.
  64. Randell RL, Stern SM, Van Mater H, Schanberg LE, Lieberman SM, Basiaga ML, CARRA Sjögren Workgroup, CARRA Investigator (2022). Pediatric rheumatologists' perspectives on diagnosis, treatment, and outcomes of Sjögren disease in children and adolescents. Pediatric rheumatology online journal, 20(1), 79.
  65. Woo JMP, Simmonds F, Dennos A, Son MBF, Lewandowski LB, Rubinstein TB, CARRA Registry investigator (2023). Health Equity Implications of Missing Data Among Youths With Childhood-Onset Systemic Lupus Erythematosus: A Proof-of-Concept Study in the Childhood Arthritis and Rheumatology Research Alliance Registry. Arthritis care & research, 75(11), 2285-2294.
  66. Verstegen RHJ, Shrader P, Balevic SJ, Beukelman T, Correll C, Dennos A, Phillips T, Feldman BM, CARRA Registry Investigator (2023). Dosing Variation at Initiation of Adalimumab and Etanercept and Clinical Outcomes in Juvenile Idiopathic Arthritis: A Childhood Arthritis and Rheumatology Research Alliance Registry Study. Arthritis care & research, 75(2), 410-422.
  67. Randell RL, Singler L, Cunningham A, Schanberg LE, Cohen-Wolkowiez M, Hornik CP, Balevic SJ, with the CARRA Registry investigator (2021). Delivering clinical trials at home: protocol, design and implementation of a direct-to-family paediatric lupus trial. Lupus science & medicine, 8(1),
  68. Beukelman T, Lougee A, Matsouaka RA, Collier D, Rumsey DG, Schenfeld J, Stryker S, Twilt M, Kimura Y, CARRA Registry Investigator (2021). Patterns of etanercept use in juvenile idiopathic arthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry. Pediatric rheumatology online journal, 19(1), 131.
  69. Roberts JE, Berbert L, Chang J, Son MBF, Childhood Arthritis and Rheumatology Research Alliance Registry Investigator (2022). Association of Race and Ethnicity With Medication Use for Pediatric Lupus in the Childhood Arthritis and Rheumatology Research Alliance Registry. ACR open rheumatology, 4(11), 954-963.
  70. Tanner TI, Agalliu I, Wahezi DM, Rubinstein T, CARRA Registry Investigator (2024). Relationship of ultraviolet light exposure and cutaneous and systemic disease activity in youth with childhood-onset systemic lupus: Results from the Childhood Arthritis and Rheumatology Research Alliance Registry. Research square,
  71. Hahn T, Daymont C, Beukelman T, Groh B, Hays K, Bingham CA, Scalzi L, CARRA Registry investigator (2022). Intraarticular steroids as DMARD-sparing agents for juvenile idiopathic arthritis flares: Analysis of the Childhood Arthritis and Rheumatology Research Alliance Registry. Pediatric rheumatology online journal, 20(1), 107.
  72. Robinson AB, Hoeltzel MF, Wahezi DM, Becker ML, Kessler EA, Schmeling H, Carrasco R, Huber AM, Feldman BM, Reed AM, Juvenile Myositis CARRA Subgroup, for the CARRA Registry Investigator (2014). Clinical characteristics of children with juvenile dermatomyositis: the Childhood Arthritis and Rheumatology Research Alliance Registry. Arthritis care & research, 66(3), 404-10.
  73. Kimura Y, Weiss JE, Haroldson KL, Lee T, Punaro M, Oliveira S, Rabinovich E, Riebschleger M, Antón J, Blier PR, Gerloni V, Hazen MM, Kessler E, Onel K, Passo MH, Rennebohm RM, Wallace CA, Woo P, Wulffraat N, Childhood Arthritis Rheumatology Research Alliance Carra Net Investigator (2013). Pulmonary hypertension and other potentially fatal pulmonary complications in systemic juvenile idiopathic arthritis. Arthritis care & research, 65(5), 745-52.
  74. Rumsey DG, Lougee A, Matsouaka R, Collier DH, Schanberg LE, Schenfeld J, Shiff NJ, Stoll ML, Stryker S, Weiss PF, Beukelman T, Childhood Arthritis and Rheumatology Research Alliance Registry Investigator (2021). Juvenile Spondyloarthritis in the Childhood Arthritis and Rheumatology Research Alliance Registry: High Biologic Use, Low Prevalence of HLA-B27, and Equal Sex Representation in Sacroiliitis. Arthritis care & research, 73(7), 940-946.
  75. Ong MS, Ringold S, Kimura Y, Schanberg LE, Tomlinson GA, Natter MD, CARRA Registry Investigator (2021). Improved Disease Course Associated With Early Initiation of Biologics in Polyarticular Juvenile Idiopathic Arthritis: Trajectory Analysis of a Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans Study. Arthritis & rheumatology (Hoboken, N.J.), 73(10), 1910-1920.
  76. Janow G, Schanberg LE, Setoguchi S, Hasselblad V, Mellins ED, Schneider R, Kimura Y, CARRA Legacy Registry Investigator (2016). The Systemic Juvenile Idiopathic Arthritis Cohort of the Childhood Arthritis and Rheumatology Research Alliance Registry: 2010-2013. The Journal of rheumatology, 43(9), 1755-62.
  77. Li SC, Torok KS, Rabinovich CE, Dedeoglu F, Becker ML, Ferguson PJ, Hong SD, Ibarra MF, Stewart K, Pope E, Higgins GC, Laxer RM, Mason T 2nd, Fuhlbrigge RC, Andrews T, CARRA Registry Investigator (2020). Initial Results from a Pilot Comparative Effectiveness Study of 3 Methotrexate-based Consensus Treatment Plans for Juvenile Localized Scleroderma. The Journal of rheumatology, 47(8), 1242-1252.
  78. Li SC, Fuhlbrigge RC, Laxer RM, Pope E, Ibarra MF, Stewart K, Mason T 2nd, Becker ML, Hong S, Dedeoglu F, Torok KS, Rabinovich CE, Ferguson PJ, Punaro M, Feldman BM, Andrews T, Higgins GC, CARRA Registry Investigator (2019). Developing comparative effectiveness studies for a rare, understudied pediatric disease: lessons learned from the CARRA juvenile localized scleroderma consensus treatment plan pilot study. Pediatric rheumatology online journal, 17(1), 43.
  79. Mannion ML, Xie F, Horton DB, Ringold S, Correll CK, Dennos A, Beukelman T, CARRA Registry Investigator (2021). Biologic Switching Among Nonsystemic Juvenile Idiopathic Arthritis Patients: A Cohort Study in the Childhood Arthritis and Rheumatology Research Alliance Registry. The Journal of rheumatology, 48(8), 1322-1329.
  80. Weiss PF, Beukelman T, Schanberg LE, Kimura Y, Colbert RA, CARRA Registry Investigator (2012). Enthesitis-related arthritis is associated with higher pain intensity and poorer health status in comparison with other categories of juvenile idiopathic arthritis: the Childhood Arthritis and Rheumatology Research Alliance Registry. The Journal of rheumatology, 39(12), 2341-51.
  81. Randell RL, Ardalan K, Carson NB, Li Z, Dedeoglu F, Weitzman ER, von Scheven E, Vehe RK, Gaultney AC, Kimura Y, Schanberg LE, Reeve BB, CARRA Registry Investigator (2026). Sex Differences in PROMIS Pediatric Depressive Symptoms, Anxiety, and Psychological Stress Among Children and Adolescents Living With Pediatric Rheumatic Diseases. The Journal of rheumatology,
  82. Jones JT, Smith C, Becker ML, Lovell D, CARRA Registry Investigator (2021). Down Syndrome-Associated Arthritis Cohort in the New Childhood Arthritis and Rheumatology Research Alliance Registry: Clinical Characteristics, Treatment, and Outcomes. Arthritis care & research, 73(12), 1739-1745.
  83. Cooper JC, Rouster-Stevens K, Wright TB, Hsu JJ, Klein-Gitelman MS, Ardoin SP, Schanberg LE, Brunner HI, Eberhard BA, Wagner-Weiner L, Mehta J, Haines K, McCurdy DK, Phillips TA, Huang Z, von Scheven E, CARRA registry investigator (2018). Pilot study comparing the childhood arthritis and rheumatology research alliance consensus treatment plans for induction therapy of juvenile proliferative lupus nephritis. Pediatric rheumatology online journal, 16(1), 65.
  84. Soulsby WD, Boscardin J, Knight A, Horton DB, Toupin-April K, von Scheven E, CARRA Registry Investigators and for the CARRA Health Equity Work Grou (2026). Cumulative Social Disadvantage and Disease Activity in Juvenile Idiopathic Arthritis: A Childhood Arthritis and Rheumatology Research Alliance Registry Study. Arthritis care & research,
  85. Chan YN, Ardalan K, Lin L, Chen D, Weitzman ER, Dedeoglu F, Vehe RK, von Scheven E, Kimura Y, Schanberg LE, Reeve BB, CARRA Registry Investigator (2026). Congruence Between Child Self-Reported and Caregiver-Proxy-Reported Health-Related Quality of Life in Children With Juvenile Idiopathic Arthritis and Systemic Lupus Erythematosus. The Journal of rheumatology,

Review

  1. Vazzana KM, Daga A, Goilav B, Ogbu EA, Okamura DM, Park C, Sadun RE, Smitherman EA, Stotter BR, Dasgupta A, Knight AM, Hersh AO, Wenderfer SE, Lewandowski LB, CARRA Registry investigator (2021). Principles of pediatric lupus nephritis in a prospective contemporary multi-center cohort. Lupus, 30(10), 1660-1670.
  2. Kimura Y, Ringold S, Riordan ME, Tomlinson G, Gaizo VD, Murphy K, Dennos A, Weiss PF, Feldman B, Natter M, Schanberg L, The CARRA STOP-JIA Investigator (2021).

Case Report

  1. Sampert C, Lowichik A, Rollins M, Inman CJ, Bohnsack J, Pohl J (2011). Sclerosing mesenteritis in a child with celiac disease. Journal of pediatric gastroenterology and nutrition, 53(6), 688-90.
  2. Sampert C, Lowichik A, Rollins M, Inman CJ, Bohnsack J, Pohl J (2011). Sclerosing mesenteritis in a child with celiac disease. Journal of pediatric gastroenterology and nutrition, 53(6), 688-90.

Other

  1. Saper VE, Chen G, Deutsch GH, Guillerman RP, Birgmeier J, Jagadeesh K, Canna S, Schulert G, Deterding R, Xu J, Leung AN, Bouzoubaa L, Abulaban K, Baszis K, Behrens EM, Birmingham J, Casey A, Cidon M, Cron RQ, De A, De Benedetti F, Ferguson I, Fishman MP, Goodman SI, Graham TB, Grom AA, Haines K, Hazen M, Henderson LA, Ho A, Ibarra M, Inman CJ, Jerath R, Khawaja K, Kingsbury DJ, Klein-Gitelman M, Lai K, Lapidus S, Lin C, Lin J, Liptzin DR, Milojevic D, Mombourquette J, Onel K, Ozen S, Perez M, Phillippi K, Prahalad S, Radhakrishna S, Reinhardt A, Riskalla M, Rosenwasser N, Roth J, Schneider R, Schonenberg-Meinema D, Shenoi S, Smith JA, Sönmez HE, Stoll ML, Towe C, Vargas SO, Vehe RK, Young LR, Yang J, Desai T, Balise R, Lu Y, Tian L, Bejerano G, Davis MM, Khatri P, Mellins ED, Childhood Arthritis and Rheumatology Research Alliance Registry Investigators (2019). Emergent high fatality lung disease in systemic juvenile arthritis. Annals of the rheumatic diseases, 78(12), 1722-1731.